Medicare billing address
CMS Medicare provider billing file
555 W Sr 164Salem, UT 84653
CMS public data · NPI 1104875574
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Tala'At Al-Shuqairat, MD
Specialty
Credential
MD
NPI
1104875574
Primary source state
UT
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Tala'At Al-Shuqairat, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
555 W Sr 164CMS Doctors & Clinicians file
555 W SrIn the 2024 CMS provider billing file, this NPI had 703 Medicare beneficiaries and 2,917 total services. The average beneficiary age was 74, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$175,045.30
Total Medicare payment amount
$134,925.75
Medicare beneficiaries
703
Total services
2,917
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
69%
CMS beneficiary-panel share
Asthma
39%
CMS beneficiary-panel share
Ischemic heart disease
37%
CMS beneficiary-panel share
Mood disorders
36%
CMS beneficiary-panel share
Depression
35%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Test to determine lung volumes using gas dilution or washout | 379 | $41.09 |
| Test to examine how well the lungs exchange gases | 379 | $51.83 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 336 | $35.84 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 308 | $15.43 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 301 | $119.50 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 277 | $112.66 |
| Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 183 | $0.04 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 110 | $115.73 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 81 | $169.39 |
| Insertion of needle into vein for collection of blood sample | 75 | $8.46 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1104875574. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Fluticasone Propionate | Fluticasone Propionate | 158 | 426.9 | $4,447.38 |
| 2 | Montelukast Sodium | Montelukast Sodium | 141 | 387.7 | $2,220.52 |
| 3 | Albuterol Sulfate Hfa | Albuterol Sulfate | 133 | 155.3 | $3,913.61 |
| 4 | Omeprazole | Omeprazole | 72 | 198.7 | $1,543.14 |
| 5 | Ipratropium Bromide | Ipratropium Bromide | 59 | 120.2 | $2,224.48 |
| 6 | Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 58 | 78 | $13,517.85 |
| 7 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 56 | 115 | $11,744.00 |
| 8 | Symbicort | Budesonide/Formoterol Fumarate | 56 | 112 | $25,753.29 |
| 9 | Prednisone | Prednisone | 54 | 62.3 | $167.06 |
| 10 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 54 | 89 | $56,842.38 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1998
Group/practice field
Revere Health Pc
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Critical Care (Intensivists).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.